When was Reshape Biotech founded?

Reshape Biotech was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Where is Reshape Biotech located?

Reshape Biotech is headquartered in Kongens Lyngby, Denmark.

Who is the current CEO of Reshape Biotech?

Carl-Emil Grøn of Reshape Biotech. They have also founded 1 company.

How many employees does Reshape Biotech have?

As of Aug 31, 2026, the latest employee count at Reshape Biotech is 63.

Is Reshape Biotech a funded company?

Reshape Biotech is a funded company, having raised a total of $29.2M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2021.

When was the latest funding round of Reshape Biotech?

Reshape Biotech's latest funding was a $***** Series A round on Apr 09, 2024, with participation from 6 investors.

Where does Reshape Biotech rank among its competitors?

Reshape Biotech ranks 13th amongst 35 active competitors, of which 10 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Automata, which secured $45M in Jan, 2026.

Who are the top competitors of Reshape Biotech?

Reshape Biotech's top competitors include Automata, Opentrons and MEGAROBO. Among them, Automata secured the most recent funding round in January, 2026.

Reshape Biotech - 2026 Company Profile, Team, Funding & Competitors

Reshape Biotech is a series A company based in Kongens Lyngby (Denmark), founded in 2018 by Magnus Madsen, Carl-Emil Grøn and Daniel Storgaard. It operates as a Provider of scalable robotic platform. Reshape Biotech has raised $29.2M in funding from investors like Y Combinator, ACME and Astanor. The company has 35 active competitors, including 10 funded and 7 that have exited. Its top competitors include companies like Automata, Opentrons and MEGAROBO.

Company Details

Provider of scalable robotic platform. It provides automated imaging and incubation capabilities, designed for data-driven decision making in microbiology research and development labs. Its also designed to simplify routine tasks, freeing up scientists to focus on more complex research and collaboration.

Website: reshapebiotech.com
Email ID: *****@reshapebiotech.com
Phone Number: +45 **********

Key Metrics

Founded Year

2018

Location

Kongens Lyngby, Denmark

Stage

Series A

Total Funding

$29.2M in 4 rounds

Latest Funding Round

Series A, Apr 09, 2024, $*****

Investors

Y Combinator & 12 more

Ranked

13^th among 35 active competitors

Employee Count

63 as on Aug 31, 2026

Similar Companies

Automata & 33 more

View Reshape Biotech's full profile

Reshape Biotech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Reshape ApS CIN: 40056173 , Denmark, Active		-	32 (As on Mar 31, 2024)

Reshape Biotech has raised a total funding of $29.2M over 4 rounds. Its first funding round was on 2021. Its latest funding round was a Series A round on Apr 09, 2024 for $*****. 6 investors participated in its latest round. Reshape Biotech has 10 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Reshape Biotech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 09, 2024	4656271	Series A	2921375	8499897	1608726	7515602
Feb 09, 2023	2609014	Seed	8795024	9466793	3869011	FundersClub & 3 more
May 23, 2021	3282333	Seed	2562204	6643439	2800933	Charlie Songhurst & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Reshape Biotech's funding rounds and investors

The founders of Reshape Biotech are Magnus Madsen, Carl-Emil Grøn and Daniel Storgaard. Carl-Emil Grøn is the CEO of Reshape Biotech.

Here are the details of Reshape Biotech's key team members:

Magnus Madsen: Co-founder and Chief Revenue Officer of Reshape Biotech.
Carl-Emil Grøn: CEO & Co-founder of Reshape Biotech.
Daniel Storgaard: Co-Founder of Reshape Biotech.
Contact Info: 1 email address

View details of Reshape Biotech's Founder profiles and Board Members

Reshape Biotech's employee count trend

Reshape Biotech has 63 employees as of Aug 26. Here is Reshape Biotech's employee count trend over the years:

Employee count trend for Reshape Biotech

Uncover Reshape Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Reshape Biotech include Automata, Opentrons and MEGAROBO. Here is the list of Top 10 competitors of Reshape Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Automata 2015, London (United Kingdom), Series C	Developer of modular lab automation platforms for biological research workflows	$177M	Dimension, Hummingbird Ventures & 27 others	67/100
2nd	Opentrons 2013, Brooklyn (United States), Series C	Developer of pipetting robot for lab automation	$261M	SoftBank Group, HAX & 23 others	61/100
3rd	MEGAROBO 2016, Beijing (China), Series C	Provider of robotic solutions for industrial laboratory automation	$427M	Inno Angel Fund, Joy Capital & 19 others	60/100
4th	Medra 2021, San Francisco (United States), Series A	Developer of robots to automate repetitive wet lab tasks	$63M	Human Capital, LDV Partners & 13 others	56/100
5th	Transcriptic 2012, Menlo Park (United States), Series A	Provider of a cloud-based remote robotic bio-lab	$27.7M	DCVC, Founders Fund & 22 others	54/100
6th	Andrew Alliance 2011, Vernier (Switzerland), Acquired	Provider of automated liquid handling tools and software for scientific labs	$14M	Rancilio Cube SICAF, Omega Funds & 4 others	46/100
7th	Chemspeed 1997, Fullinsdorf (Switzerland), Acquired	Designer and manufacturer of lab instruments and consumables for R&D industries	-	Investnet	44/100
8th	Protedyne 2000, Windsor Locks (United States), Acquired	Develops robotic platform for laboratory automation	$22M	Allen & Company, New Leaf Venture Partners ... & 5 others	43/100
9th	Flow Robotics 2015, Copenhagen (Denmark), Series A	Provider of an AI-based laboratory automation robot system for liquid handling	$17.1M	Vaekstfonden, ITU Business Development & 1 others	42/100
10th	Benyao Technology 2021, Shanghai (China), Series A	Robotics and artificial intelligence technology to provide automation solutions	$29.1M	Panlin Capital, Boyuan Capital & 3 others	39/100
13th	Reshape Biotech 2018, Kongens Lyngby (Denmark), Series A	Provider of scalable robotic platform	$29.2M	FundersClub, FCVC & 11 others	38/100